Profile data is unavailable for this security.
About the company
SciClone Pharmaceuticals Holdings Ltd is a China-based biopharmaceutical company principally engaged in developing and commercializing a portfolio of marketed products as well as pipeline with potential in its focused therapeutic areas including oncology and severe infection. The Company primarily engages in the sales of its proprietary product, Zadaxin, its in-licensed products and promotion products on behalf of its business partners in China.
- Revenue in HKD (TTM)3.40bn
- Net income in HKD1.21bn
- Incorporated2020
- Employees1.05k
- LocationSciClone Pharmaceuticals (Holdings) Ltd22/FCentral Plaza, 381 Middle Huaihai RoadSHANGHAI ChinaCHN
- Websitehttps://www.sciclone.com/
More ▼